HELX vs. XOMO
HELX (Franklin Genomic Advancements ETF) and XOMO (YieldMax XOM Option Income Strategy ETF) are both exchange-traded funds - HELX is a Health & Biotech Equities fund actively managed by Franklin Templeton, while XOMO is a Derivative Income fund actively managed by YieldMax. Both are actively managed. Over the past year, HELX returned 39.97% vs 29.93% for XOMO. Their -0.00 correlation means they have often moved in opposite directions in the past. HELX charges 0.50%/yr vs 1.01%/yr for XOMO.
Performance
HELX vs. XOMO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HELX achieves a 6.95% return, which is significantly lower than XOMO's 20.26% return.
HELX
- 1D
- -2.30%
- 1M
- -5.21%
- 6M
- 6.44%
- YTD
- 6.95%
- 1Y
- 39.97%
- 3Y*
- 7.91%
- 5Y*
- -5.94%
- 10Y*
- —
- ALL TIME*
- 7.84%
XOMO
- 1D
- -1.31%
- 1M
- 10.95%
- 6M
- 6.18%
- YTD
- 20.26%
- 1Y
- 29.93%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 7.86%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $176.38K | $146.45K | $86.79K | |
| $613.93K | $674.71K | $709.58K |
HELX vs. XOMO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
HELX Franklin Genomic Advancements ETF | 6.95% | 26.34% | -5.32% | -1.52% |
XOMO YieldMax XOM Option Income Strategy ETF | 20.26% | 6.90% | 6.11% | -8.59% |
Correlation
The correlation between HELX and XOMO is -0.31, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.31 |
Correlation (All Time) Calculated using the full available price history since Aug 31, 2023 | -0.00 |
Over the past year, the inverse relationship between HELX and XOMO has strengthened: their correlation has moved from -0.00 to -0.31, meaning they now move in opposite directions more often than their long-term average.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HELX vs. XOMO — Risk / Return Rank
HELX
XOMO
HELX vs. XOMO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and YieldMax XOM Option Income Strategy ETF (XOMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HELX | XOMO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.47 | ||
| Sortino ratioReturn per unit of downside risk | +0.70 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.25 | +0.06 |
| Calmar ratioReturn relative to maximum drawdown | 2.25 | 1.64 | +0.60 |
| Martin ratioReturn relative to average drawdown | 5.64 | 4.12 | +1.52 |
Loading charts...
Drawdowns
HELX vs. XOMO - Drawdown Comparison
The maximum HELX drawdown since its inception was -58.75%, which is greater than XOMO's maximum drawdown of -18.90%. Use the drawdown chart below to compare losses from any high point for HELX and XOMO.
Loading charts...
Drawdown Indicators
| HELX | XOMO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.75% | -18.90% | -39.85% |
Max Drawdown (1Y)Largest decline over 1 year | -18.01% | -17.25% | -0.76% |
Max Drawdown (3Y)Largest decline over 3 years | -29.48% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -58.75% | — | — |
Current DrawdownCurrent decline from peak | -32.89% | -7.57% | -25.32% |
Average DrawdownAverage peak-to-trough decline | -34.28% | -7.50% | -26.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.16% | 6.90% | +0.26% |
Volatility
HELX vs. XOMO - Volatility Comparison
Franklin Genomic Advancements ETF (HELX) and YieldMax XOM Option Income Strategy ETF (XOMO) have volatilities of 6.37% and 6.19%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HELX | XOMO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.37% | 6.19% | +0.18% |
Volatility (6M)Calculated over the trailing 6-month period | 17.71% | 17.25% | +0.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.01% | 20.68% | +1.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.05% | 19.20% | +4.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.32% | 19.20% | +8.12% |
HELX vs. XOMO - Expense Ratio Comparison
HELX has a 0.50% expense ratio, which is lower than XOMO's 1.01% expense ratio.
Dividends
HELX vs. XOMO - Dividend Comparison
HELX's dividend yield for the trailing twelve months is around 0.37%, less than XOMO's 37.04% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
HELX Franklin Genomic Advancements ETF | 0.37% | 0.39% | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% |
XOMO YieldMax XOM Option Income Strategy ETF | 37.04% | 31.64% | 26.94% | 5.13% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
HELX and XOMO have a correlation of -0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HELX has higher volatility (6.37%) compared to XOMO (6.19%). In terms of maximum drawdown, HELX dropped -58.75% vs XOMO's -18.90%.
On 1-year performance, HELX leads with 39.97% vs 29.93% for XOMO. On fees, HELX is cheaper at 0.50% per year. On volatility, XOMO has been the lower-risk option at 6.19%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, HELX has performed better with a 39.97% return vs 29.93%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
HELX is cheaper with a 0.50% expense ratio, compared with 1.01% for XOMO.
XOMO has the higher dividend yield at 37.04%, compared with 0.37% for HELX.
HELX is categorized as Health & Biotech Equities, while XOMO is Derivative Income. They also come from different issuers: Franklin Templeton and YieldMax. Their fees differ too: 0.50% for HELX and 1.01% for XOMO.
HELX currently has the higher Sharpe Ratio (1.84 vs 1.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HELX and XOMO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer